BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25023063)

  • 1. Regulation of RIG-I-like receptor signaling by host and viral proteins.
    Chiang JJ; Davis ME; Gack MU
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):491-505. PubMed ID: 25023063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular pathogen detection by RIG-I-like receptors.
    Dixit E; Kagan JC
    Adv Immunol; 2013; 117():99-125. PubMed ID: 23611287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological functions of RIG-I-like receptors.
    Yoneyama M; Kato H; Fujita T
    Immunity; 2024 Apr; 57(4):731-751. PubMed ID: 38599168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIG-I-like receptor regulation in virus infection and immunity.
    Chan YK; Gack MU
    Curr Opin Virol; 2015 Jun; 12():7-14. PubMed ID: 25644461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of RLR-mediated innate immune signaling--it is all about keeping the balance.
    Eisenächer K; Krug A
    Eur J Cell Biol; 2012 Jan; 91(1):36-47. PubMed ID: 21481967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulators of the RIG-I-like receptor signaling pathway.
    Quicke KM; Diamond MS; Suthar MS
    Eur J Immunol; 2017 Apr; 47(4):615-628. PubMed ID: 28295214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity.
    Errett JS; Gale M
    Virol Sin; 2015 Jun; 30(3):163-73. PubMed ID: 25997992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensing viral invasion by RIG-I like receptors.
    Yoo JS; Kato H; Fujita T
    Curr Opin Microbiol; 2014 Aug; 20():131-8. PubMed ID: 24968321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens.
    Gack MU
    J Virol; 2014 May; 88(10):5213-6. PubMed ID: 24623415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of melanoma differentiation-associated gene 5 (MDA5)-dependent antiviral innate immune responses by Arf-like protein 5B.
    Kitai Y; Takeuchi O; Kawasaki T; Ori D; Sueyoshi T; Murase M; Akira S; Kawai T
    J Biol Chem; 2015 Jan; 290(2):1269-80. PubMed ID: 25451939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of antiviral innate immune signaling by stress-induced RNA granules.
    Yoneyama M; Jogi M; Onomoto K
    J Biochem; 2016 Mar; 159(3):279-86. PubMed ID: 26748340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paramyxovirus V protein interaction with the antiviral sensor LGP2 disrupts MDA5 signaling enhancement but is not relevant to LGP2-mediated RLR signaling inhibition.
    Rodriguez KR; Horvath CM
    J Virol; 2014 Jul; 88(14):8180-8. PubMed ID: 24829334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral RNA detection by RIG-I-like receptors.
    Yoneyama M; Onomoto K; Jogi M; Akaboshi T; Fujita T
    Curr Opin Immunol; 2015 Feb; 32():48-53. PubMed ID: 25594890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune signaling by RIG-I-like receptors.
    Loo YM; Gale M
    Immunity; 2011 May; 34(5):680-92. PubMed ID: 21616437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication.
    Kell AM; Hemann EA; Turnbull JB; Gale M
    PLoS Pathog; 2020 Apr; 16(4):e1008483. PubMed ID: 32330200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS.
    Wang P; Yang L; Cheng G; Yang G; Xu Z; You F; Sun Q; Lin R; Fikrig E; Sutton RE
    Cell Rep; 2013 Apr; 3(4):1057-70. PubMed ID: 23545497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.
    Onomoto K; Onoguchi K; Yoneyama M
    Cell Mol Immunol; 2021 Mar; 18(3):539-555. PubMed ID: 33462384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.